Related Experiment Video
Updated: May 31, 2026
04:42
Bacterial Cellulose Spheres that Encapsulate Solid Materials
Published on: February 26, 2021
Bacterial cellulose: long-term biocompatibility studies
Renata A N Pértile1, Susana Moreira, Rui M Gil da Costa
1a IBB, Institute for Biotechnology and Bioengineering, Universidade do Minho , Campus de Gualtar , 4710-057 , Braga , Portugal.
Journal of Biomaterials Science. Polymer Edition
|July 5, 2011
Summary
Bacterial cellulose (BC) implants showed mild inflammation and no foreign body reaction in mice. BC nanofibres accumulated in macrophages but did not cause bone marrow toxicity, suggesting good biocompatibility for tissue engineering.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Immunology
Background:
- Bacterial cellulose (BC) is a pure cellulose nanofiber network with high crystallinity and mechanical strength.
- Its properties make it suitable for tissue-engineering applications, including artificial vascular grafts.
- Understanding the in vivo biocompatibility of BC is crucial for its clinical translation.
Purpose of the Study:
- To evaluate the in vivo biocompatibility of bacterial cellulose (BC) membranes and nanofibres.
- To assess the inflammatory response and potential toxicity of BC implants in mice.
- To investigate the long-term effects of BC subcutaneous implants on host tissues and bone marrow.
Main Methods:
- Histological analysis of subcutaneous BC membrane implants in mice over extended periods.
- Subcutaneous implantation of BC nanofibres followed by histological and bone marrow flow cytometry analyses.
- Comparison of implanted animals with control groups to assess systemic effects.
Main Results:
- BC implants induced a mild, transient inflammatory reaction without a foreign body response.
- A tendency for calcification was observed in less porous BC implants over time.
- BC nanofibres were internalized by macrophages but did not induce toxicity in bone marrow cell populations.
Conclusions:
- Bacterial cellulose (BC) exhibits favorable biocompatibility for subcutaneous implantation.
- BC membranes and nanofibres present a low risk of systemic toxicity.
- Further research into porosity and calcification may optimize BC for vascular graft applications.
